Abstract
Introduction mTOR is abbreviated from the 'mammalian target of rapamycin'. The lipophilic macrolide rapamycin (or sirolimus) is used as an immunosuppressant and an anti-cancer drug. Rapamycin inhibits cell proliferation and growth through its specific interaction with a cellular protein receptor called FK506-binding protein (FKBP12)
. Through molecular modifications induced by rapamycin, two genes, TOR1 and TOR2, were found in mammalian cells [1] . Correspondingly, two functionally distinct proteins called mTORC1 and mTORC2, each with a molecular mass of 1.5-2.0 MD, were identified by gel filtration [4] [5] [6] . This implies that mTOR associates with many distinct cellular protein complexes. The molecular weight of mTOR itself is approximately 250-290 kD. Only mTORC1 is sensitive to rapamycin [7] [8] [9] 
. The carboxy-terminal region of mTOR contains the FKBP12-rapamycin binding (FRB) domain, the catalytic domain that shows homology to phosphatidylinositol kinases, and the FATC sequence. The amino-terminal region of mTOR contains~2 0 tandem HEAT repeats (each HEAT repeat consists of two ␣ helices of Ͻ40 amino acids, each with a specific pattern of hydrophobic and hydrophilic residues), the so-called FAT domain (for FRAP, ATM, TRAP) [10]. Although mTOR contains a lipid kinase-like domain within its C-terminal region, it does not possess detectable lipid kinase activity, but instead it functions as a serine / threonine (S/T) kinase.
Cell signalling through mTOR is regulated by cellular energy level as well as by mitogens and nutrients [1] . As [20] [21] [22] , p-eukaryotic initiation factor 2 alpha (eIF2␣) [22] , and p-p70S6K at the T389 site or at the T421/S424 sites [23] . [24] . A␤ toxicity was able to activate PKR through calcium signalling and caspase 8 activation [25] . Increased PKR expression in AD brains was confirmed by other groups [20, 21] , and augmented levels of p-PKR were also found in APP/PS1 knock-in mice [26] . In AD brains, activated PKR was observed in the cytoplasm of hippocampal neurons and in the neuronal nucleus of other cortical areas such as the frontal cortex.
PKR is a pro-apoptotic kinase that attenuates protein translation through the regulation of eIF2␣ phosphorylation. In 2002, Chang et al. [22] reported an increased expression of p-PKR and p-eIF2␣ in degenerating hippocampal neurons of AD brains. Also in 2002, the same group published another study showing that A␤ peptide was able to activate PKR and that A␤ neurotoxicity was reduced in cultured neurons originating from PKR knock-out mice
Intraneuronally, p-p70S6K appeared especially in neurons that are predicted to develop NFTs at later stages [23] . [27, 28] . The increase of mTOR-dependent signalling was positively and significantly correlated with total tau and p-tau. The mTOR-dependent signalling is thought to be involved in the translation of a special group of proteins including tau with 5'top mRNA. Thus, it is speculated that the decade-long continuous synthesis of tau in degenerating neurons is regulated by up-regulated mTOR-dependent signalling through the p70S6K and 4E-BP1 pathways [29] .
By indirect enzyme-linked immunosorbent assay, p-p70S6K (T389 or T421/S424) studies showed significant increases in homogenates of the medial temporal cortex from 22 AD patients as compared to 13 control brains. In the same set of tissues from AD and control cases, we found a dramatic increase for p-eIF4E, p-mTOR (S2481) and p-4E-BP1 (T70 and S65) in AD brains
The total level of eukaryotic elongation factor 2 (eEF2) is significantly decreased in AD when compared to controls [28] [30, 31] . Global protein synthesis during tissue acidosis was inhibited as eEF2K is activated in a pH-dependent manner [32] . Although these two pathological conditions showed opposite effects on the level of tau phosphorylation, an increase during ischaemia and a decrease during hypoxia [33, 34] , yet acidic brain pH values in AD brains [35] might activate eEF2K, thus causing reduced global translation [28, 36, 37] . Global inhibition of protein synthesis is widely recognized as a response of biological systems to oxidative stress [38, 39] . But the translation of some proteins is not inhibited and the translational control of specific mRNAs is required for survival during cell growth under stress conditions [40, 41] . This mechanism might give the exposed cells an enhanced ability of resistance to the onset of neurodegeneration (as will be discussed later). Ribosomes (polyribosomes) are specialized complexes that are responsible for mediating protein synthesis, and they are composed of nucleic acids and proteins. Specialized nucleic acids, rRNA and tRNA molecules, are essential for ribosomes to translate mRNA into proteins. There is a significant impairment in ribosome function in AD brains [36, 37] [48, 50] . [15, 49] [15, 49] . [48, 51] 
The main difference in these experiments is that zinc was added to the culture media after cells were starved for 1 or 2 days, while A␤42 was added to differentiated N2a cells and differentiated SH-SY5Y cells without equilibrium time for cells to react to 10% serum deprivation after retinoic acid treatment [15, 49]. The dramatic reduction of p-mTOR seen in differentiated N2a cells should be considered as the combined effects of two cell stresses: serum deprivation and A␤42 treatment [49]. It is interesting to note that p-p70S6K expression in cells exposed to the sudden serum deprivation and A␤42 treatment was different from p-mTOR expression in both differentiated N2a cells and differentiated SH-SY5Y cells

. The increase in p-p70S6K levels in differentiated SH-SY5Y cells treated with A␤42 [15] is approximately consistent with the augmentation seen in undifferentiated SH-SY5Y cells treated with 100 M zinc [48]. Another difference is that when tau phosphorylation was investigated, only the bottom-attached cells were harvested. In other experiments, at the end of the treatment, attached cells and cells collected from the supernatant after centrifugation (apoptotic or necrotic cells) were analysed
Levels of p-mTOR at the S2448 site and of p70S6K at the T389 site are decreased in the cortex but not in the cerebellum (devoid of plaques) of double APP/PS1 transgenic mice (carrying the Swedish and London mutations KM670/671 and V717, thy 1 promoter) compared with control mice [49]. However, in SH-SY5Y cells treated with 20 M A␤, p-mTOR at the 2448 site was downregulated and both p-ERK1/2 and p-p70S6K at the T421/S424 sites (15 min.) and at the T389 site (30 min.) were up-regulated [15]. The reduced mTOR phosphorylation is associated with caspase 3 activation, and the inhibition of mTOR by rapamycin enhances A␤-induced cell death [15]. A similar response of ERK1/2 and p70S6K was observed in rat brain slices exposed to the selective inhibition of protein phosphatase (PP) -2A or in human SH-SY5Y cells treated with 100 M zinc
Tau phosphorylation mediated by mTOR-dependent signalling
In SH-SY5Y cells and primary cultured neurons from rat cortical cortex that are treated with 100 M zinc, an increased expression and phosphorylation of tau was observed [23, 52] 
. Pretreatment of cells with rapamycin attenuated the effects induced by zinc. Recently, it was found that inhibition of mTOR and the phosphoinositide 3-kinase signalling pathway activates PP2A and glycogen synthase kinase 3␤ (GSK3␤), the coordinated regulation of PP2A
and GSK3␤ is thought to ensure a balanced tau phosphorylation [53] . The direct role of p70S6K on tau phosphorylation was observed in vitro on S262, S214 and T212 sites [54, 55] 
mTOR-dependent signalling in lymphocytes of AD patients: potential biomarkers for AD diagnosis
The control of protein translation involving mTOR, p70S6K, eIF␣ and PKR modulates cell survival and cell death, and these proteins are increased in AD brains [20-23, 27, 28] [49, 57] . For example, the p-p70S6K/ total p70S6K ratio was reduced in AD patients compared to control individuals, and the p-PKR/total PKR ratio was increased in AD patients and their levels statistically were correlated (positively or negatively) with Mini Mental Status Examination scores or scores of cued recall tests [58, 59] . It is unknown why the lymphocytes of AD patients display modified levels of activated kinases that are implicated in the control of translation and cell survival. Previous reports have emphasized the altered characteristics of lymphocytes in AD patients, such as increased sensitivity to apoptosis [57, 59] [66, 67] and that neuronal apoptosis, linked to MK801 administration in rats, is associated with tau de-phosphorylation [68] . Another report has demonstrated that tau de-phosphorylation occurs at the onset of the execution phase of apoptosis and is due to the activation of PP2A-like phosphatase in cerebellar neurons [69] 
. Studies from Hugon and colleagues demonstrated that expressions of p-p70S6K, p-mTOR, p-eIF␣ and p-PKR are significantly modified in the lymphocytes of AD patients
Conclusions
The role of mTOR activation in neurodegenerative diseases, especially in AD, seems to be very complex. mTOR is mainly a trophic and protective kinase for neurons but could also be activated sometimes during the progress of neuronal apoptosis. Similarly, an mTOR inhibitor was reported to be a pro-apoptotic agent, but could alleviate the pathological consequences in a murine model of Huntington disease. These seemingly conflicting results were made more complex by the involvement of mTOR in neurofibrillary degeneration. mTOR is also implicated in the molecular mechanisms of learning and memory [12] that are impaired in AD. It is believed that mTOR is involved in the regulation of neuronal reactions, dependent on the exposure dose of stress, duration of stress, and the ability of the neurons to tolerate the stresses (Fig. 2) . The understanding of these differences in neuronal sensitivities could open new avenues of research for neuroprotection. 
